Matsumoto Yushi-Seiyaku Co., Ltd.
【Matsumoto Oil & Fat Pharmaceutical】2026 Financial Results | Revenue approximately 590 million yen / Net profit approximately 1.92 million yen
Matsumoto Oil & Fat Pharmaceutical's FY2026 financial results show revenue of approximately 590 million yen and net profit of approximately 1.92 million yen. Share buyback and shareholder composition are also disclosed.
Key Figures
- Revenue: 5,932,457 thousand yen
- Net income: 191,911 thousand yen
- Number of treasury shares: 94,500 shares
AI要約
Performance Overview
Matsumoto Oil & Fat Pharmaceutical's FY2026 financial results show revenue of approximately 590 million yen and net profit of approximately 1.92 million yen. Revenue compared to the previous year is unknown, but operating income was 97,686 thousand yen, and ordinary income was 219,553 thousand yen, indicating steady performance. The financial position includes total assets of 1.719 billion yen, and it holds 94,500 shares of treasury stock.
Shareholder Composition and Future Outlook
The major shareholder is MK Holdings, which owns 100%. The management team includes President and CEO Naoki Kimura among four members. The company's financial foundation is stable, and future efforts are expected to focus on steady business operations and shareholder returns.
Matsumoto Oil & Fat Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
